Telemonitoring of Heart Failure becomes Standard Care
2 February 2022
With pioneering research on the use of implants and external sensors in telemonitoring, BIOTRONIK (IN-TIME) and GETEMED, together with the Charité (TIM-HF & TIM-HF2), have actively shaped the way for efficient management of heart failure.
We have accompanied these landmark studies, the evidence from which enables their use in standard care for hundreds of thousands of patients.
As of 01.01.2022, we are launching our solution inCareNet HF, together with Biotronik. It combines telemedical data from implants and external sensors into a holistic care platform for heart failure.
More on compensation can be found here.